Skip to main content

Whalen Amanda's Form 4 filing

Klaviyo, Inc. (KVYO) · filed Nov 18, 2025

Accession no.
0001470831-25-000332
Filed
Nov 18, 2025
Trade date
Nov 14-15, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $428.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Whalen AmandaCIK 0001991131Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 14, 2025Series A Common StockCConversionAcquired+15,000–F2–496,719Direct
Nov 14, 2025Series A Common StockSSaleDisposed−14,700$28.61F3−$420,567482,019Direct
Nov 14, 2025Series A Common StockSSaleDisposed−300$27.89F4−$8,367481,719Direct
Nov 15, 2025Series A Common StockCConversionAcquired+29,513–F2–511,232Direct
Nov 15, 2025Series A Common StockFTax withholdingDisposed−45,058$28.61−$1,289,109.38466,174Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 14, 2025Series A Common StockCConversionDisposed−15,000$0.00$0378,476Direct
Nov 15, 2025Series A Common StockCConversionDisposed−29,513$0.00$0348,963Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.

Referenced by the price of 2 transactions in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.96 to $28.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.805 to $27.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)